NEUROCENTRX PHARMA LIMITED
13 years
Company Age
Active
Status
72110
Industry
Edinburgh
Location
359
days
Accounts Due
30 Sep 2027
450
days
CT600 Due
30 Dec 2027
Key Dates
Last Accounts Filed
31 December 2025
Financial Year End
31 December 2026
Confirmation Statement
241 days
4 June 2027
Accounts Due
359 days
30 September 2027
CT600 Due
450 days
30 December 2027
Financial Snapshot 2023
Revenue
£0
Profit
-£3.3M
-41.5%
Net Assets
-£320K
-148.6%
Cash
£130K
- Company Type
- Ltd
- Incorporated
- 18 July 2013
- Registered Address
- Level 5, 9 Haymarket Square, Edinburgh, EH3 8RY
- SIC Codes
-
- 72110
Browse Similar Companies
Similar companies in Edinburgh
Active companies with the same industry classification (SIC 72110).
- DAMIAN MOLE LIFE SCIENCES LTD SC831251
- PHASE BIOLABS SCOTLAND LTD SC831350
- NODUS ONCOLOGY LIMITED SC658917
- EP PHARMACEUTICALS LTD SC439312
- ROSLIN CELL THERAPIES LIMITED SC512315
- CARITAS BIOSCIENCE LTD SC522121
- CUMULUS ONCOLOGY LIMITED SC581311
- CARCINOTECH LTD SC604026
When are NEUROCENTRX PHARMA LIMITED's accounts due?
NEUROCENTRX PHARMA LIMITED's next accounts are due by 30 September 2027 (359 days from now).
Is NEUROCENTRX PHARMA LIMITED still trading?
Yes, NEUROCENTRX PHARMA LIMITED is currently Active according to Companies House records.
What does NEUROCENTRX PHARMA LIMITED do?
NEUROCENTRX PHARMA LIMITED is classified as 72110.
How old is NEUROCENTRX PHARMA LIMITED?
NEUROCENTRX PHARMA LIMITED was incorporated on 18 July 2013 and is 13 years old.